FAST Act Modernization and Simplification of Regulation S-K, 13796 [C1-2019-05695]
Download as PDF
<![CDATA[
13796
Federal Register / Vol. 84, No. 67 / Monday, April 8, 2019 / Rules and Regulations
than an assessment every two years) due
to concerns not meeting several VWP
requirements. In 2016, DHS extended
Greece’s VWP designation on a
provisional basis through March 31,
2017, to address concerns over migrant
vetting, information-sharing gaps, and
passport-issuance practices.
Additionally, DHS reduced Greece’s
ESTA validity period from two years to
one year and committed Greece to
implement five lines of effort specified
in a Joint Statement in order to remove
Greece from a provisional VWP status.
In 2017, DHS sent correspondence to
Greece defining a set of actions that
would justify ESTA normalization.
Greece has made successful progress in
all five lines of effort and has completed
all of the elements required for ESTA
normalization that had been
communicated in 2017. Greece has
enacted necessary legislation to
authorize issuance and replacement of
national identification cards (biometric
chip), expanded systematic refugee
vetting at all migrant processing centers,
and enacted Passenger Name
Recognition (PNR) legislation to
implement the EU PNR Directive. For
these reasons, DHS is publishing this
document announcing that it is
increasing Greece’s ESTA validity
period to two years.
Claire Grady,
Senior Official Performing the Duties of the
Deputy Secretary, Department of Homeland
Security.
[FR Doc. 2019–06750 Filed 4–5–19; 8:45 am]
BILLING CODE P
SECURITIES AND EXCHANGE
COMMISSION
17 CFR Parts 229, 230, 232, 239, 240,
249, 270, 274, and 275
[Release No. 33–10618; 34–85381; IA–5206;
IC–33426; File No. S7–08–17]
RIN 3235–AM00
FAST Act Modernization and
Simplification of Regulation S–K
jbell on DSK30RV082PROD with RULES
Correction
In rule document 2019–05695,
appearing on pages 12674 through
12738, in the issue of Tuesday, April 2,
2019, make the following corrections:
1. On page 12675, in the table, in the
second column, in the tenth line from
the top of the page, the text entry that
reads ‘‘§ 249.218’’ should read
‘‘§ 249.220f’’.
VerDate Sep<11>2014
15:49 Apr 05, 2019
Jkt 247001
PART 249—FORMS, SECURITIES
EXCHANGE ACT OF 1934 [Corrected]
2. On page 12729, in the second
column, five asterisks (* * * * *)
indicating the existence of text not
listed and unchanged should appear
above the text reading ‘‘INSTRUCTIONS
AS TO EXHIBITS’’.
■
[FR Doc. C1–2019–05695 Filed 4–5–19; 8:45 am]
BILLING CODE 1301–00–D
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
21 CFR Part 1308
[Docket No. DEA–446]
Schedules of Controlled Substances:
Extension of Temporary Placement of
5F–ADB, 5F–AMB, 5F–APINACA, ADB–
FUBINACA, MDMB–CHMICA and
MDMB–FUBINACA in Schedule I of the
Controlled Substances Act
Drug Enforcement
Administration, Department of Justice.
ACTION: Temporary rule; temporary
scheduling order; extension.
AGENCY:
The Acting Administrator of
the Drug Enforcement Administration is
issuing this temporary scheduling order
to extend the temporary schedule I
status of six synthetic cannabinoids
(SC). The substances are: methyl 2-(1-(5fluoropentyl)-1H-indazole-3carboxamido)-3,3-dimethylbutanoate
[5F–ADB; 5F–MDMB–PINACA]; methyl
2-(1-(5-fluoropentyl)-1H-indazole-3carboxamido)-3-methylbutanoate [5F–
AMB]; N-(adamantan-1-yl)-1-(5fluoropentyl)-1H-indazole-3carboxamide [5F–APINACA, 5F–
AKB48]; N-(1-amino-3,3-dimethyl-1oxobutan-2-yl)-1-(4-fluorobenzyl)-1Hindazole-3-carboxamide [ADB–
FUBINACA]; methyl 2-(1(cyclohexylmethyl)-1H-indole-3carboxamido)-3,3-dimethylbutanoate
[MDMB–CHMICA, MMB–CHMINACA]
and methyl 2-(1-(4-fluorobenzyl)-1Hindazole-3-carboxamido)-3,3dimethylbutanoate [MDMB–
FUBINACA], including their optical,
positional and geometric isomers, salts,
and salts of isomers. The schedule I
status of 5F–ADB, 5F–AMB, 5F–
APINACA, ADB–FUBINACA, MDMB–
CHMICA and MDMB–FUBINACA will
expire on April 10, 2019. This
temporary order will extend the
temporary scheduling of 5F–ADB, 5F–
AMB, 5F–APINACA, ADB–FUBINACA,
MDMB–CHMICA and MDMB–
FUBINACA for one year or until the
permanent scheduling action for these
SUMMARY:
PO 00000
Frm 00002
Fmt 4700
Sfmt 4700
six substances is completed, whichever
occurs first.
DATES: This temporary scheduling
order, which extends the order (82 FR
17119, April 10, 2017), is effective April
10, 2019 and expires on April 10, 2020.
If DEA publishes a final rule making
this scheduling action permanent, this
order will expire on the effective date of
that rule, if the effective date is earlier
than April 10, 2020.
FOR FURTHER INFORMATION CONTACT:
Lynnette M. Wingert, Diversion Control
Division, Drug Enforcement
Administration; Mailing Address: 8701
Morrissette Drive, Springfield, Virginia
22152; Telephone: (202) 598–6812.
SUPPLEMENTARY INFORMATION:
Background and Legal Authority
On April 10, 2017, the Acting
Administrator of the Drug Enforcement
Administration (DEA) published an
order in the Federal Register (82 FR
17119) temporarily placing methyl 2-(1(5-fluoropentyl)-1H-indazole-3carboxamido)-3,3-dimethylbutanoate
[5F–ADB; 5F–MDMB–PINACA], methyl
2-(1-(5-fluoropentyl)-1H-indazole-3carboxamido)-3-methylbutanoate [5F–
AMB], N-(adamantan-1-yl)-1-(5fluoropentyl)-1H-indazole-3carboxamide [5F–APINACA, 5F–
AKB48], N-(1-amino-3,3-dimethyl-1oxobutan-2-yl)-1-(4-fluorobenzyl)-1Hindazole-3-carboxamide [ADB–
FUBINACA], methyl 2-(1(cyclohexylmethyl)-1H-indole-3carboxamido)-3,3-dimethylbutanoate
[MDMB–CHMICA, MMB–CHMINACA]
and methyl 2-(1-(4-fluorobenzyl)-1Hindazole-3-carboxamido)-3,3dimethylbutanoate [MDMB–
FUBINACA], synthetic cannabinoid
(SC) substances, in schedule I of the
Controlled Substances Act (CSA)
pursuant to the temporary scheduling
provisions of 21 U.S.C. 811(h). That
order was effective on the date of
publication, and was based on findings
by the Acting Administrator of the DEA
that the temporary scheduling of these
SCs was necessary to avoid an imminent
hazard to the public safety pursuant to
21 U.S.C. 811(h)(1). Section 201(h)(2) of
the CSA, 21 U.S.C. 811(h)(2), requires
that the temporary control of these
substances expires two years from the
effective date of the scheduling order, or
on April 10, 2019. However, the CSA
also provides that during the pendency
of proceedings under 21 U.S.C. 811(a)(1)
with respect to the substance, the
temporary scheduling 1 of that substance
1 Though DEA has used the term ‘‘final order’’
with respect to temporary scheduling orders in the
past, this notice adheres to the statutory language
of 21 U.S.C. 811(h), which refers to a ‘‘temporary
E:\FR\FM\08APR1.SGM
08APR1
]]>Agencies
[Federal Register Volume 84, Number 67 (Monday, April 8, 2019)]
[Rules and Regulations]
[Page 13796]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: C1-2019-05695]
=======================================================================
-----------------------------------------------------------------------
SECURITIES AND EXCHANGE COMMISSION
17 CFR Parts 229, 230, 232, 239, 240, 249, 270, 274, and 275
[Release No. 33-10618; 34-85381; IA-5206; IC-33426; File No. S7-08-17]
RIN 3235-AM00
FAST Act Modernization and Simplification of Regulation S-K
Correction
In rule document 2019-05695, appearing on pages 12674 through
12738, in the issue of Tuesday, April 2, 2019, make the following
corrections:
1. On page 12675, in the table, in the second column, in the tenth
line from the top of the page, the text entry that reads ``Sec.
249.218'' should read ``Sec. 249.220f''.
PART 249--FORMS, SECURITIES EXCHANGE ACT OF 1934 [Corrected]
0
2. On page 12729, in the second column, five asterisks (* * * * *)
indicating the existence of text not listed and unchanged should appear
above the text reading ``INSTRUCTIONS AS TO EXHIBITS''.
[FR Doc. C1-2019-05695 Filed 4-5-19; 8:45 am]
BILLING CODE 1301-00-D
